Navigation Links
Poniard Pharmaceuticals to Present at Needham & Company's Cancer Therapeutics: Today & Tomorrow Conference
Date:3/19/2009

SOUTH SAN FRANCISCO, Calif., March 19 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and CEO, will present at the Needham & Company Cancer Therapeutics: Today & Tomorrow Conference on Thursday, March 26, at 10 a.m. Eastern Time in New York.

Dr. McMahon will provide a corporate overview, including a discussion of the clinical development program for picoplatin, the Company's lead product candidate.

A live audio webcast of the presentation will be available for 10 business days on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum chemotherapy. To date, clinical studies suggest that picoplatin has an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. Clinical trials of intravenous picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal and castration-resistant (hormone-refractory) prostate cancers. The Company also is conducting a clinical trial of oral picoplatin in solid tumors. For additional information please visit http://ww
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Poniard Pharmaceuticals Receives Going Concern Qualification
2. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
3. Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin
4. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
5. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
6. Poniard Pharmaceuticals Announces Upcoming Conference Participation
7. Statement by Teva Pharmaceuticals on Eshoo-Barton Bill
8. China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores
9. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
10. Meditor Pharmaceuticals (North American) Ltd. announces the closing of a merger agreement with American Medical Technologies, Inc.
11. Gamma Pharmaceuticals Accepts PO From Leading St. Louis Missouri Distributor. Order Valued up to $850,000 Retail Market Value

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ov. 8 Pharmaceutical Re... Vice President Ken Johnson released the following...bill: ,, "We are disappointed, but not surprise...ons of hardworking Americans as well as nearly hal...ves who voted against the bill. ,, "While well ...
(Date:11/8/2009)... House Passage of Health Care Reform Bill ,, ...prove coverage for all Americans ,, BALTIMORE,...ght the United States House of Representatives pas...ould strengthen Medicare for seniors and end discr...ons of Americans out of affordable health coverage...
(Date:11/7/2009)... 7 The American Medical...irector of Health at the Family Violence Preventio...e today at its semi-annual policy-making meeting. ...hest honor the AMA House of Delegates bestows on a...om.com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Ms...
(Date:11/7/2009)...thful Catholics have a responsibility to vigorousl... status quo." ,, WASHINGTON, Nov. 7 /PRNews...t Judie Brown released the following statement on ...Speaker Nancy Pelosi,s Affordable Health Care for ...serving the status quo for abortion is voted upon....
(Date:11/7/2009)...sume that all youth will rebel, expert says , ...re more likely to behave badly if their parents ex...ts who believe they are simply being realistic mig...cy," Christy Buchanan, a psychology professor at W...said in a university news release. "Negative expec...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2
...studies done at the Yale school of medicine, and r...e get when we eat certain foodstuffs//, like garli...d Wasabi’s. The sensory receptor they ay also unde...receptor drugs used for treatment of cancer, arthr...
... conducted by Columbia University Medical Center h...ded for use in osteoarthritis, could be effective/...l. Until now, drug treatment with Cox-2 inhibitors...geons annually, according to estimates of the Nati...
...ection and treatment of tuberculosis in the state ...tween the public//, private health care sectors an...n organized at Bangalore, as a part of the Interna...ing responsible for poor control of TB in the stat...
...ean breast cancer conference (EBCC-5) had doctors,...cancer research and improve patient care//. Breast...omen. But as of now the survival rates are improvi...on for Research and Treatment of Cancer (EORTC) an...
...l wake up to a fresh dawn tomorrow - A ban that pr... at the crack of dawn// on Sunday. Scotland will a... be the first part of Britain to ban smoking in pu...iven it the sobriquet "sick man of Europe". ...
...China who perceive themselves as being fat, despit...isk of developing depression and school-related st...rs. This could be due to an inclination to Western...different Chinese studies. Teenage girls who said ...
Other Medicine News:Health News:Sodium Hyaluronate Shows Promise In Treatment Of Shoulder Pain 2Health News:Obese Chinese Teens Low On Self-Esteem 2
(Date:11/6/2009)...OUSTON, Nov. 6 Cyberonic...company will report financial results for the seco...ar ending April 30, 2010 on Wednesday, November 18... conference call to discuss those results on Thurs...cal Year 2010 Second Quarter Results Conference Ca...
(Date:11/6/2009)...ETROIT, Nov. 6 Caraco Ph... has launched ketorolac tromethamine ophthalmic so...S Food and Drug Administration (FDA) for Sun Pharm...neric Acular® opthalmic solution on the first... ketorolac is therapeutically equivalent to Acular...
(Date:11/5/2009)...ATONTOWN, N.J., Nov. 5 O...merging field of biologic products for regenerativ...e third quarter ended September 30, 2009. ,, "D...the release of our three new biologic products Ma...ology and Plexur M® Innovative Grafting," sai...
Breaking Medicine Technology:Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Gen Probe to Webcast Two Upcoming Investor Presentations 12480 1Gen Probe to Webcast Two Upcoming Investor Presentations 12480 2Maggianos Little Italy 28R 29 Celebrates Sixth Annual Eat A Dish for Make A Wish 28R 29 in Chicago 48012 1Maggianos Little Italy 28R 29 Celebrates Sixth Annual Eat A Dish for Make A Wish 28R 29 in Chicago 48012 2Maggianos Little Italy 28R 29 Celebrates Sixth Annual Eat A Dish for Make A Wish 28R 29 in Chicago 48012 3Maggianos Little Italy 28R 29 Celebrates Sixth Annual Eat A Dish for Make A Wish 28R 29 in Chicago 48012 4Trubion to Present at the 8th Annual Needham Life Sciences Conference 48008 1Trubion to Present at the 8th Annual Needham Life Sciences Conference 48008 2
...armaceuticals,Inc. today announced the issuance of...against human aspartyl (asparaginyl) beta-hydroxyl...nd therapeutic target. These antibodies,were devel...tute of,Technology (MIT) and Panacea has exclusive...of human cancer diagnostics and therapeutics. Pana...
... Evidence Pycnogenol(R) Lowers Joint, Pain, Sympto...g Cessation of the Ext...nter for,Disease Control (CDC), osteoarthritis, th...new study published in the August journal of Phyto...act from the French maritime pine,tree, reduced ov...
Other Medicine Technology:Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4
PROFILE Titanium Cannulated Interference Screws
PHANTOM SofThread Cannulated Interference Screws
PHANTOM Absorbable Cannulated Interference Screws
Mini Arthroscope
Medicine Products: